PHOENIX: QL1706 Plus Chemotherapy and Bevacizumab in AGA-Resistant, PD-L1 ≥50% Non-Squamous NSCLC
Clinical trial NCT07416058 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07416058
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-31
- Primary completion
- 2027-12-31
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.